CD24 Protein-VLP, Cynomolgus, Recombinant

CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers. CD24 Protein-VLP, Cynomolgus, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 3.8 kDa and the accession number is XP_015304503.1.

规格	价格/CNY		数量
100 μg	￥ 11,800	5日内发货
500 μg	￥ 47,500	5日内发货
1 mg	￥ 79,100	5日内发货

规格

价格/CNY

货期

数量

100 μg

￥ 11,800

5日内发货

500 μg

￥ 47,500

5日内发货

1 mg

￥ 79,100

5日内发货

产品描述

种属	Cynomolgus
表达系统	HEK293 Cells
蛋白编号	XP_015304503.1
别名	MGC75043, CD 24, FLJ43543, FLJ22950, CD24 molecule, CD24A
蛋白构建	Ser26-Gly57
蛋白纯度	> 90% as determined by HPLC
分子量	3.8 kDa (predicted)

内毒素	< 1 EU/μg by the LAL method.
缓冲液	Supplied as 0.22 μm filtered solution in PBS (pH 7.4).Notice: If you need it for immunization, Do Not use any adjuvant.
存储	It is recommended to store the product under sterile conditions at -70℃ or lower. Samples are stable for up to 12 months at -80℃. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式	In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
研究背景	CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers.